oral cancer

Under the terms of the deal, MDxHealth and QUT will evaluate and develop the test, which will evaluate abnormal DNA methylation changes.

By analyzing mutations in tumors from a broad swath of tobacco smoke-related cancer types, investigators identified more than two-dozen mutational signatures.

This Week in PNAS

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

The firm's PCR-based products for HPV-associated cancers look at DNA methylation at specific genes and include several sample preparation kits.

The kit targets several mRNA biomarkers and is the first in a series of salivary diagnostic kits the firm plans to develop for early-stage disease diagnostics.

Researchers saw high recurrence risk in oropharyngeal carcinoma patients with human papillomavirus type 16 DNA in their spit samples both before and after treatment.

Researchers hope to advance the technology to support an assay to help personalize oral cancer treatment by avoiding the development of mucositis.

NEW YORK (GenomeWeb) – Canadian molecular diagnostics company Proteocyte Diagnostics today said that it closed a funding round that raised C$605,000 (US$554,000).

NEW YORK (GenomeWeb News) – LED Medical Diagnostics this week announced an agreement to form a collaboration to develop and commercialize a progression-risk assessment test for oral cancer.

NEW YORK (GenomeWeb News) – The National Institute of Dental and Craniofacial Research plans to award $1.5 million next year to fund researchers delving into the molecular and cell-level biology of cancer initiating cells (CICs), also called cancer stem cells, which may be involved in oral cancer

Pages

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.